• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Sanofi (Group) [since May 2011]

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

	Start	2011-05-06 renamed
	Predecessor	Sanofi-Aventis (Group)
	Industry	pharmaceutical
	Person	Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough)
	Person 2	Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18)
	Region	Paris
	Country	France
	Street	174 avenue de France
	City	75635 Paris
	Tel	+33-1-5377-4000
		Address record changed: 2020-12-02
Basic data	Employees	I: 50,001 to 100,0 (2021-12-31)
	Currency	EUR
	Annual sales	37,761,000,000 (sales, net, consolidated (2021) 2021-12-31)
	Profit	6,279,000,000 (2021-12-31)
	Cash	10,098,000,000 (2021-12-31)
		* Document for �About Section�:
		Record changed: 2022-03-31

Advertisement

More documents for Sanofi (Group) [since May 2011]

• [1] Sanofi S.A.. (3/29/22). "Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets". Paris....
• [2] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
• [3] Sanofi S.A.. (3/15/22). "Press Release: Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma". Paris....
• [4] Sanofi S.A.. (2/8/22). "Press Release: Sanofi Completes Acquisition of Amunix". Paris....
• [5] Exscientia plc. (1/7/22). "Press Release: Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines". Paris, Oxford & Boston, MA....
• [6] Sanofi S.A.. (12/21/21). "Press Release: Sanofi to Acquire Amunix Immuno-oncology Pipeline with Next Generation Conditionally Activated Biologics". Paris....
• [7] Sanofi S.A.. (11/18/21). "Press Release: Sanofi Invests $180 Million Equity in Owkin’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline". Paris....
• [8] CRISPR Therapeutics AG. (10/14/21). "Press Release: CRISPR Therapeutics Announces Transition of Chief Financial Officer". Zug & Cambridge, MA....
• [9] MoonLake Immunotherapeutics AG. (8/10/21). "Press Release: MoonLake Immunotherapeutics Appoints Former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors". Zug....
• [10] Sanofi S.A.. (8/3/21). "Press Release: Sanofi to Acquire Translate Bio, Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development". Paris & Lexington, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.